Last reviewed · How we verify

Fosphenytoin Injection

Dhaka Medical College · FDA-approved active Small molecule Quality 0/100

Fosphenytoin Injection is a Small molecule drug developed by Dhaka Medical College. It is currently FDA-approved. Also known as: Fosfen Injection.

At a glance

Generic nameFosphenytoin Injection
Also known asFosfen Injection
SponsorDhaka Medical College
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fosphenytoin Injection

What is Fosphenytoin Injection?

Fosphenytoin Injection is a Small molecule drug developed by Dhaka Medical College.

Who makes Fosphenytoin Injection?

Fosphenytoin Injection is developed and marketed by Dhaka Medical College (see full Dhaka Medical College pipeline at /company/dhaka-medical-college).

Is Fosphenytoin Injection also known as anything else?

Fosphenytoin Injection is also known as Fosfen Injection.

What development phase is Fosphenytoin Injection in?

Fosphenytoin Injection is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing